Drug safety evaluation, also known as non-clinical drug safety evaluation, refers to the safety evaluation of therapeutic drugs through laboratory research and animal in vitro system, which is a necessary procedure and an important step before new drugs enter the final clinical trial and final approval.
Drug safety should first draw up plans and agreements. These studies, such as general acute and chronic toxicity studies, histopathological studies, reproductive toxicity tests, genotoxicity studies, safety pharmacology studies, investigation studies, toxicity and safety biomarkers studies.
Due to the very successful methods in the series of molecular biology, including chapters briefly introducing their respective disciplines, lists of required materials, step-by-step and easy-to-repeat schemes, and tips for troubleshooting and avoiding known traps. Comprehensive authority, drug safety evaluation: as an ideal guide in this field, the scheme and scheme can help pharmaceutical scientists, toxicologists, biochemists and molecular biologists, as well as all relevant scientists who want to transform into other disciplines to understand the toxicity information of related drugs.